Occupational Activity – Page 20

Bayer’s Q3 Earnings Plummet 37%, CEO Urges Patience Amid Performance-Boosting Strategy

10 months ago talkbio0Tagged Avian crop, Bayer, Bill Anderson, CEO, decline, earnings, generics, Kerendia, Nubeqa, performance-boosting strategy

Bayer, Q3 earnings, decline, CEO Bill Anderson, performance-boosting strategy, pharmaceuticals, crop science, generics, Xarelto, Nubeqa, Kerendia.

Eisai Slashes Leqembi Sales Forecast Amid Continued Launch Challenges

10 months ago talkbio0Tagged Alzheimer 's disease, Biogen, Drug Industry, Eisai, Leqembi, Projections and Predictions, Sales - occupational activity

Eisai, Leqembi, Alzheimer’s disease, sales forecast, revenue expectations, Biogen, pharmaceutical industry

Charles River Laboratories Embarks on Restructuring, Closing 15 Smaller Sites Amid Declining Demand for Early Research Services

10 months ago talkbio0Tagged Charles, cost-cutting measures, Declining, Demand (clinical), Industry, Reparative closure, restructuring, River Laboratories

Charles River Laboratories, restructuring, site closures, declining demand, early research services, cost-cutting measures, biotech industry challenges.

Merck Reports Strong Q3 Results but Lowers Full-Year Sales Guidance

11 months ago talkbio0Tagged Advice, Capvaxive, full-year, Gardasil, Januvia, Keytruda, Merck, results, Sales - occupational activity, Winrevair

Merck, Q3 Results, Full-Year Sales Guidance, Keytruda, Gardasil, Januvia, Winrevair, Capvaxive

Insights from Jade CEO: Reverse Merger and IgAN Drug Development

11 months ago talkbio0Tagged biotech, CEO, Drug Development, IGA Glomerulonephritis, mergers, reverse merger

Jade CEO, Reverse Merger, IgAN Drugs, Pharmaceutical Development, Biotech Mergers

Biopharma Industry Alarmed by Prospect of RFK Jr. Shaping FDA Policies Under Trump Administration

11 months ago talkbio0Tagged Administration occupational activities, Agriculture, Biopharma, Health care facility, Policy, RFK Jr., Transplant Registry Unified Management Program, United States Food and Drug Administration

RFK Jr., FDA, Trump Administration, Biopharma, Healthcare Policy, Agriculture Policy

WuXi AppTec Faces Uncertainty Amid BIOSECURE Act, Yet Continues to Secure New Projects

11 months ago talkbio0Tagged AppTec, Biopharma, BIOSECURE, CDMOs, Contract agreement, Industry, Legislation, manufacturing organizations, National Security Concerns, Outsourcing, United States, WuXi

BIOSECURE Act, WuXi AppTec, Biotechnology Industry, U.S. Legislation, Contract Development and Manufacturing Organizations (CDMOs), Biopharma Outsourcing, National Security Concerns